Top Imperial College London Oncology Researcher Discusses the Quest for HCC Biomarkers

Top Imperial College London Oncology Researcher Discusses the Quest for HCC Biomarkers

The hunt for biomarkers for patients with hepatocellular carcinoma (HCC) or liver cancer ensues as an explosion of novel agents, either approved or in the clinical trials pipeline, opens the door for tremendous opportunity to develop heretofore not possible treatments...
Therapy Advancements and Biomarker Identifications Leading to Improved Ability to Predict and Enhance Responses To Immunotherapeutic Agents In Non–Small Cell Lung Cancer (NSCLC)

Therapy Advancements and Biomarker Identifications Leading to Improved Ability to Predict and Enhance Responses To Immunotherapeutic Agents In Non–Small Cell Lung Cancer (NSCLC)

Targeted therapy advancements and the identification of emerging biomarkers of response to treatment have led to an improved ability to predict and enhance responses to immunotherapeutic agents in non–small cell lung cancer (NSCLC). Available agents that have...
China Medical University-Led Biomarker Study: KRT17 Spurs Non-Small Cell Lung Cancer

China Medical University-Led Biomarker Study: KRT17 Spurs Non-Small Cell Lung Cancer

Chinese investigators studied Keratin 17 (KRT17), a 48KDa type I intermediate filament, which is mainly expressed in epithelial basal cells. KRT17 has been shown to be overexpressed in many malignant tumors and play an important role in the occurrence and development...

Pin It on Pinterest